These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35340220)

  • 1. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
    Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
    Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.
    Zhang L; Wei Y; He Y; Wang X; Huang Z; Sun L; Chen J; Zhu Q; Zhou X
    Cancer Med; 2023 Feb; 12(4):4907-4920. PubMed ID: 36030492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
    Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.
    Shi Y; Ma X; Wang M; Lan S; Jian H; Wang Y; Wei Q; Zhong F
    Cancer Cell Int; 2022 May; 22(1):188. PubMed ID: 35568883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker.
    Liu K; Cui L; Li C; Tang C; Niu Y; Hao J; Bu Y; Chen B
    Front Genet; 2022; 13():922472. PubMed ID: 35991576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
    Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
    Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers.
    Cui Z; Mo J; Song P; Wang L; Wang R; Cheng F; Wang L; Zou F; Guan X; Zheng N; Yang X; Wang W
    Front Genet; 2022; 13():1000339. PubMed ID: 36199577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico analysis of expression pattern of a Wnt/β-catenin responsive gene ANLN in gastric cancer.
    Pandi NS; Manimuthu M; Harunipriya P; Murugesan M; Asha GV; Rajendran S
    Gene; 2014 Jul; 545(1):23-9. PubMed ID: 24809965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer.
    Zhou W; Wang Z; Shen N; Pi W; Jiang W; Huang J; Hu Y; Li X; Sun L
    Mol Cell Biochem; 2015 Jan; 398(1-2):11-9. PubMed ID: 25223638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
    Jia H; Yu F; Li B; Gao Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23635. PubMed ID: 33089886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
    Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
    Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
    Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
    BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.
    Wang G; Shen W; Cui L; Chen W; Hu X; Fu J
    Cancer Biomark; 2016; 16(3):459-65. PubMed ID: 27062703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
    Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive multiomics and in silico approach uncovers prognostic, immunological, and therapeutic roles of ANLN in lung adenocarcinoma.
    Singh P; Arora S; Beg MA; Sahoo S; Nayek A; Khan MM; Sinha A; Malik MZ; Athar F; Serajuddin M; Dohare R; Syed MA
    Funct Integr Genomics; 2023 Jul; 23(3):223. PubMed ID: 37410302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma.
    Lian YF; Huang YL; Wang JL; Deng MH; Xia TL; Zeng MS; Chen MS; Wang HB; Huang YH
    Aging (Albany NY); 2018 Aug; 10(8):1884-1901. PubMed ID: 30103211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
    Chen S; Gao Y; Chen F; Wang TB
    Urol Int; 2023; 107(3):310-320. PubMed ID: 35504258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
    Dai X; Chen X; Hakizimana O; Mei Y
    Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.